Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study
<p>Abstract</p> <p>Background</p> <p>Several different gene expression signatures have been proposed to predict response to therapy and clinical outcome in lung adenocarcinoma. Herein, we investigate if elements of published gene sets can be reproduced in a small datase...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-03-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/77 |
id |
doaj-3cf9acaa2195420db129570fee7cde27 |
---|---|
record_format |
Article |
spelling |
doaj-3cf9acaa2195420db129570fee7cde272020-11-24T21:15:43ZengBMCBMC Cancer1471-24072010-03-011017710.1186/1471-2407-10-77Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray studyPasslick BernwardAumann KonradWiech ThorstenKayser GianFeuerhake FriedrichNeumann JensFisch PaulWerner Martinzur Hausen Axel<p>Abstract</p> <p>Background</p> <p>Several different gene expression signatures have been proposed to predict response to therapy and clinical outcome in lung adenocarcinoma. Herein, we investigate if elements of published gene sets can be reproduced in a small dataset, and how gene expression profiles based on limited sample size relate to clinical parameters including histopathological grade and EGFR protein expression.</p> <p>Methods</p> <p>Affymetrix Human Genome U133A platform was used to obtain gene expression profiles of 28 pathologically and clinically annotated adenocarcinomas of the lung. EGFR status was determined by fluorescent in situ hybridization and immunohistochemistry.</p> <p>Results</p> <p>Using unsupervised clustering algorithms, the predominant gene expression signatures correlated with the histopathological grade but not with EGFR protein expression as detected by immunohistochemistry. In a supervised analysis, the signature of high grade tumors but not of EGFR overexpressing cases showed significant enrichment of gene sets reflecting MAPK activation and other potential signaling cascades downstream of EGFR. Out of four different previously published gene sets that had been linked to prognosis, three showed enrichment in the gene expression signature associated with favorable prognosis.</p> <p>Conclusions</p> <p>In this dataset, histopathological tumor grades but not EGFR status were associated with dominant gene expression signatures and gene set enrichment reflecting oncogenic pathway activation, suggesting that high immunohistochemistry EGFR scores may not necessarily be linked to downstream effects that cause major changes in gene expression patterns. Published gene sets showed association with patient survival; however, the small sample size of this study limited the options for a comprehensive validation of previously reported prognostic gene expression signatures.</p> http://www.biomedcentral.com/1471-2407/10/77 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Passlick Bernward Aumann Konrad Wiech Thorsten Kayser Gian Feuerhake Friedrich Neumann Jens Fisch Paul Werner Martin zur Hausen Axel |
spellingShingle |
Passlick Bernward Aumann Konrad Wiech Thorsten Kayser Gian Feuerhake Friedrich Neumann Jens Fisch Paul Werner Martin zur Hausen Axel Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study BMC Cancer |
author_facet |
Passlick Bernward Aumann Konrad Wiech Thorsten Kayser Gian Feuerhake Friedrich Neumann Jens Fisch Paul Werner Martin zur Hausen Axel |
author_sort |
Passlick Bernward |
title |
Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study |
title_short |
Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study |
title_full |
Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study |
title_fullStr |
Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study |
title_full_unstemmed |
Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study |
title_sort |
gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to egf-r status: a microarray study |
publisher |
BMC |
series |
BMC Cancer |
issn |
1471-2407 |
publishDate |
2010-03-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Several different gene expression signatures have been proposed to predict response to therapy and clinical outcome in lung adenocarcinoma. Herein, we investigate if elements of published gene sets can be reproduced in a small dataset, and how gene expression profiles based on limited sample size relate to clinical parameters including histopathological grade and EGFR protein expression.</p> <p>Methods</p> <p>Affymetrix Human Genome U133A platform was used to obtain gene expression profiles of 28 pathologically and clinically annotated adenocarcinomas of the lung. EGFR status was determined by fluorescent in situ hybridization and immunohistochemistry.</p> <p>Results</p> <p>Using unsupervised clustering algorithms, the predominant gene expression signatures correlated with the histopathological grade but not with EGFR protein expression as detected by immunohistochemistry. In a supervised analysis, the signature of high grade tumors but not of EGFR overexpressing cases showed significant enrichment of gene sets reflecting MAPK activation and other potential signaling cascades downstream of EGFR. Out of four different previously published gene sets that had been linked to prognosis, three showed enrichment in the gene expression signature associated with favorable prognosis.</p> <p>Conclusions</p> <p>In this dataset, histopathological tumor grades but not EGFR status were associated with dominant gene expression signatures and gene set enrichment reflecting oncogenic pathway activation, suggesting that high immunohistochemistry EGFR scores may not necessarily be linked to downstream effects that cause major changes in gene expression patterns. Published gene sets showed association with patient survival; however, the small sample size of this study limited the options for a comprehensive validation of previously reported prognostic gene expression signatures.</p> |
url |
http://www.biomedcentral.com/1471-2407/10/77 |
work_keys_str_mv |
AT passlickbernward geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy AT aumannkonrad geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy AT wiechthorsten geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy AT kaysergian geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy AT feuerhakefriedrich geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy AT neumannjens geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy AT fischpaul geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy AT wernermartin geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy AT zurhausenaxel geneexpressionprofilesoflungadenocarcinomalinkedtohistopathologicalgradingandsurvivalbutnottoegfrstatusamicroarraystudy |
_version_ |
1716744306757206016 |